CREKA peptide (acetate)
CREKA peptide acetate is a short peptide sequence, belonging to self-assembling peptides (SAPs), which can self-assemble into functional nanostructures, typically nanofibers, under physiological conditions. CREKA peptide acetate can be used to target tumor cells and tumor vasculature, exhibiting antitumor activity[1].
Product Specifications
UNSPSC
12352209
Target
Biochemical Assay Reagents
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer; Cardiovascular Disease
Purity
98.07
Smiles
CC(O)=O.O=C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](C)C(O)=O)=O)=O)=O)[C@H](CS)N
Molecular Formula
C25H47N9O10S
Molecular Weight
665.76
References & Citations
[1]Zhang N, et al. Recent advances of CREKA peptide-based nanoplatforms in biomedical applications. J Nanobiotechnology. 2023 Mar 3;21 (1) :77.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
GINS1, NT (GINS1, KIAA0186, PSF1, DNA replication complex GINS protein PSF1, GINS complex subunit 1) (PE) discontinued
